Literature DB >> 10666260

Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines.

B Wölk1, D Sansonno, H G Kräusslich, F Dammacco, C M Rice, H E Blum, D Moradpour.   

Abstract

A tetracycline-regulated gene expression system and a panel of novel monoclonal antibodies were used to examine the subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus (HCV) NS3-NS4A complex in inducible cell lines. The NS3 serine protease domain and the full-length NS3 protein expressed in the absence of the NS4A cofactor were diffusely distributed in the cytoplasm and nucleus. Coexpression of NS4A, however, directed NS3 to the endoplasmic reticulum (ER) or an ER-like modified compartment, as demonstrated by colocalization with 3,3'-dihexyloxacarbocyanine iodide, protein disulfide isomerase, and calnexin, as well as subcellular fractionation analyses. In addition, coexpression with NS4A dramatically increased the intracellular stability of NS3 (mean protein half-life of 26 versus 3 h) and allowed for NS4A-dependent trans-cleavage at the NS4B-NS5A junction. Deletion analyses revealed that the hydrophobic amino-terminal domain of NS4A was required for ER targeting of NS3. These results demonstrate the importance of studying HCV proteins in their biological context and define a well-characterized cell culture system for further analyses of the NS3-NS4A complex and the evaluation of novel antiviral strategies against hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666260      PMCID: PMC111711          DOI: 10.1128/jvi.74.5.2293-2304.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions.

Authors:  R Bartenschlager; L Ahlborn-Laake; J Mous; H Jacobsen
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

2.  Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia.

Authors:  D Sansonno; V Cornacchiulo; A R Iacobelli; R Di Stefano; M Lospalluti; F Dammacco
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

3.  Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics.

Authors:  C Lin; B M Prágai; A Grakoui; J Xu; C M Rice
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Kinetic and structural analyses of hepatitis C virus polyprotein processing.

Authors:  R Bartenschlager; L Ahlborn-Laake; J Mous; H Jacobsen
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

5.  Biosynthesis and biochemical properties of the hepatitis C virus core protein.

Authors:  E Santolini; G Migliaccio; N La Monica
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins.

Authors:  C Failla; L Tomei; R De Francesco
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus.

Authors:  M Hijikata; H Mizushima; T Akagi; S Mori; N Kakiuchi; N Kato; T Tanaka; K Kimura; K Shimotohno
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing.

Authors:  Y Tanji; M Hijikata; S Satoh; T Kaneko; K Shimotohno
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

9.  Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini.

Authors:  C Lin; B D Lindenbach; B M Prágai; D W McCourt; C M Rice
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  A second hepatitis C virus-encoded proteinase.

Authors:  A Grakoui; D W McCourt; C Wychowski; S M Feinstone; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

View more
  107 in total

Review 1.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

Review 2.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

3.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.

Authors:  Kui Li; Eileen Foy; Josephine C Ferreon; Mitsuyasu Nakamura; Allan C M Ferreon; Masanori Ikeda; Stuart C Ray; Michael Gale; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

5.  Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain.

Authors:  Andrew Kohlway; Nathan Pirakitikulr; Francisco N Barrera; Olga Potapova; Donald M Engelman; Anna M Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

6.  Functional and Physical Interaction between the Arf Activator GBF1 and Hepatitis C Virus NS3 Protein.

Authors:  Nadjet Lebsir; Lucie Goueslain; Rayan Farhat; Nathalie Callens; Jean Dubuisson; Catherine L Jackson; Yves Rouillé
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 7.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

8.  In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor.

Authors:  Tse-I Lin; Oliver Lenz; Gregory Fanning; Thierry Verbinnen; Frédéric Delouvroy; Annick Scholliers; Katrien Vermeiren; Asa Rosenquist; Michael Edlund; Bertil Samuelsson; Lotta Vrang; Herman de Kock; Piet Wigerinck; Pierre Raboisson; Kenneth Simmen
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

9.  Endocytic Rab proteins are required for hepatitis C virus replication complex formation.

Authors:  David Manna; Jason Aligo; Chenjia Xu; Wei Sun Park; Hasan Koc; Won Do Heo; Kouacou V Konan
Journal:  Virology       Date:  2009-12-16       Impact factor: 3.616

10.  Replication of a cytopathic strain of bovine viral diarrhea virus activates PERK and induces endoplasmic reticulum stress-mediated apoptosis of MDBK cells.

Authors:  Robert Jordan; Lijuan Wang; Thomas M Graczyk; Timothy M Block; Patrick R Romano
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.